Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer

LESSONS LEARNED. In terms of efficacy and safety, good results were obtained with S‐1 and paclitaxel (PTX) combination therapy. The findings suggest that S‐1 and PTX combination therapy is a feasible treatment option in patients with previously treated non‐small cell lung cancer. BACKGROUND. Althoug...

Descripción completa

Detalles Bibliográficos
Autores principales: Chihara, Yusuke, Yoshimura, Akihiro, Date, Koji, Takemura, Yoshizumi, Tamiya, Nobuyo, Kohno, Yoshihito, Imabayashi, Tatsuya, Takeuchi, Mayumi, Kaneko, Yoshiko, Yamada, Tadaaki, Ueda, Mikio, Arimoto, Taichiro, Uchino, Junji, Iwasaki, Yoshinobu, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693719/
https://www.ncbi.nlm.nih.gov/pubmed/31040252
http://dx.doi.org/10.1634/theoncologist.2019-0290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693719/
https://www.ncbi.nlm.nih.gov/pubmed/31040252
http://dx.doi.org/10.1634/theoncologist.2019-0290

Ejemplares similares